ALB and type 2 diabetes mellitus: In this study, adult patients with or without type 2 diabetes mellitus (T2DM), eGFR 25-75 mL/min/1.73 m2, and albumin-to-creatinine ratio 200-5000 mg/g (20-500 mg/mmol) and who were on a stable tolerated dose of either ACEI or ARB were either randomized to dapagliflozin (10 mg daily) or placebo [8,10].